Display options
Cite
Dalrymple K, Saito EK, Diaz N, et al. Past Cigarette Smoking Is More Common among Those with Cholinergic Than Noncholinergic Dementias. Neurol Res Int. 2014;2014:423602doi: 10.1155/2014/423602.
Dalrymple, K., Saito, E. K., Diaz, N., Morrow, J., Nakamoto, B., & McMurtray, A. M. (2014). Past Cigarette Smoking Is More Common among Those with Cholinergic Than Noncholinergic Dementias. Neurology research international, 2014423602. https://doi.org/10.1155/2014/423602
Dalrymple, Kyle, et al. "Past Cigarette Smoking Is More Common among Those with Cholinergic Than Noncholinergic Dementias." Neurology research international vol. 2014 (2014): 423602. doi: https://doi.org/10.1155/2014/423602
Dalrymple K, Saito EK, Diaz N, Morrow J, Nakamoto B, McMurtray AM. Past Cigarette Smoking Is More Common among Those with Cholinergic Than Noncholinergic Dementias. Neurol Res Int. 2014;2014:423602. doi: 10.1155/2014/423602. Epub 2014 Dec 10. PMID: 25574388; PMCID: PMC4276668.
Copy Download .nbib Format: NLM
Share it on

Neurol Res Int. 2014;2014:423602. doi: 10.1155/2014/423602. Epub 2014 Dec 10.

Past Cigarette Smoking Is More Common among Those with Cholinergic Than Noncholinergic Dementias.

Neurology research international

Kyle Dalrymple, Erin K Saito, Natalie Diaz, Julia Morrow, Beau Nakamoto, Aaron M McMurtray

Affiliations

  1. Pitzer College, Claremont, CA 91711, USA.
  2. Neurology Division, Los Angeles Biomedical Research Institute, Torrance, CA 90502, USA.
  3. Neurology Division, Los Angeles Biomedical Research Institute, Torrance, CA 90502, USA ; Neurology Department, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6975, USA ; Neurology Department, Harbor-UCLA Medical Center, Building N-25, 1000 West Carson Street, Torrance, CA 90509, USA.
  4. Neurology Department, Harbor-UCLA Medical Center, Building N-25, 1000 West Carson Street, Torrance, CA 90509, USA.
  5. Neurology Department, Straub Hospital and Clinics, Honolulu, HI 96813, USA ; Neurology Division, Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA.

PMID: 25574388 PMCID: PMC4276668 DOI: 10.1155/2014/423602

Abstract

Background. Patients with progressive dementing disorders associated with cortical cholinergic dysfunction gradually develop cholinergic deficits many years before symptom onset and may begin to smoke cigarettes during midlife as a form of self-medication. The aim of this study was to compare self-reported past smoking rates between those with and without cholinergic dementias, to determine if those who developed cholinergic dementias were more likely to smoke during midlife than those who did not. Methods. Retrospective cross-sectional study of past smoking status among patients treated at an outpatient clinic during a three-year period. Results. A total of 440 patients were evaluated during the study period, including 224 with cholinergic dementias and 216 with noncholinergic dementias and controls. Past smoking rates were greater among those with cholinergic dementias compared to those without cholinergic dementias (43.92% versus 26.96%, P = 0.012). Additionally, smokers with cholinergic dementias reported significantly greater mean pack-years of smoking (P = 0.038). Conclusions. Greater midlife smoking rates and greater pack-years of smoking were associated with cholinergic dementias. These results suggest midlife smoking may be an early indicator for those developing brain cholinergic deficits related to progressive dementing disorders and support initiating treatment prior to symptom onset in cholinergic dementias.

References

  1. Aust N Z J Psychiatry. 1999 Dec;33(6):800-8 - PubMed
  2. Med J Aust. 2001 Mar 19;174(6):271-5 - PubMed
  3. PLoS One. 2012;7(5):e36752 - PubMed
  4. J Neurosci. 2006 Aug 23;26(34):8707-14 - PubMed
  5. J Neurochem. 1995 Apr;64(4):1888-91 - PubMed
  6. J Neurosci. 2003 Dec 17;23(37):11554-67 - PubMed
  7. Ann Neurol. 2001 Dec;50(6):780-6 - PubMed
  8. Int Psychogeriatr. 2002;14 Suppl 1:51-75 - PubMed
  9. PLoS One. 2014 Apr 15;9(4):e95029 - PubMed
  10. Neurology. 2000 Jan 25;54(2):407-11 - PubMed
  11. Neurology. 1999 Jan 1;52(1):115-9 - PubMed
  12. Arch Gen Psychiatry. 2006 Aug;63(8):907-15 - PubMed
  13. J Neurochem. 2000 Jan;74(1):237-43 - PubMed
  14. Neurobiol Aging. 2011 May;32(5):834-44 - PubMed
  15. Alzheimers Dement. 2012 Nov;8(6):513-9 - PubMed
  16. J Nucl Med. 2010 Sep;51(9):1418-30 - PubMed
  17. Acta Pharmacol Sin. 2009 Jul;30(7):879-88 - PubMed
  18. Lancet. 1998 Jun 20;351(9119):1840-3 - PubMed
  19. Br Med J. 1978 Nov 25;2(6150):1457-9 - PubMed
  20. Int J Geriatr Psychiatry. 2000 May;15(5):387-92 - PubMed

Publication Types

Grant support